Last updated: July 1, 2025
Sponsor: University of Oslo
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain (Pediatric)
Mild Cognitive Impairment
Dementia
Treatment
FDG-PET
EEG
Clinical Study ID
NCT04938362
Cognition/fatigue/brainabscess
Ages > 16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
• Patients who have completed treatment for brain abscess and who agree to participate.
Exclusion
Exclusion criteria:
Patients who cannot undergo neuropsychological investigation due to unconsciousness
Patients who cannot undergo neuropsychological investigation, being mentally too ill
Patients who suffer from dementia
Patients who cannot undergo FDG-PET due to claustrophobia
Patients who cannot undergo EEG due to panic attacks
Age under 16.
Study Design
Total Participants: 50
Treatment Group(s): 2
Primary Treatment: FDG-PET
Phase:
Study Start date:
January 01, 2020
Estimated Completion Date:
December 31, 2030
Study Description
Connect with a study center
Oslo University Hospital
Oslo, 0450
NorwayActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.